Trial Outcomes & Findings for Interactive Spaced Education to Optimize Hypertension Management (NCT NCT00904007)

NCT ID: NCT00904007

Last Updated: 2019-02-05

Results Overview

A unique hypertensive period served as the unit of analysis. A hypertensive period started on the first day during the study when a patient's BP was elevated. It ended on the first subsequent day when it was \<140/90 mm Hg or on the last day BP was recorded during the study. Duration of the hypertensive period (days) was the outcome measure. BP measurements obtained in the course of routine care were used to ascertain study outcomes, whether obtained by the PCP or at other clinic visits. These measurements were obtained from structured data (ie, BP recordings in the electronic medical record) and natural language processing of provider notes as previously described. If several measurements were recorded on the same day, the lowest mean arterial BP was used.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

111 participants

Primary outcome timeframe

Months 1-24

Results posted on

2019-02-05

Participant Flow

Participant milestones

Participant milestones
Measure
SE Game Cohort
SE game clinicians were e-mailed one question every 3 days. Adaptive game mechanics re-sent questions in 12 or 24 days if answered incorrectly or correctly, respectively. Clinicians retired questions by answering each correctly twice consecutively. Posting of relative performance among peers fostered competition.
Control Cohort
Control clinicians received identical educational content in an online posting with email reminders.
Overall Study
STARTED
55
56
Overall Study
COMPLETED
55
56
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Interactive Spaced Education to Optimize Hypertension Management

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
SE Game Cohort
n=55 Participants
SE game clinicians were e-mailed one question every 3 days. Adaptive game mechanics re-sent questions in 12 or 24 days if answered incorrectly or correctly, respectively. Clinicians retired questions by answering each correctly twice consecutively. Posting of relative performance among peers fostered competition.
Control Cohort
n=56 Participants
Control clinicians received identical educational content in an online posting with email reminders.
Total
n=111 Participants
Total of all reporting groups
Age, Continuous
50.5 years
STANDARD_DEVIATION 9.7 • n=99 Participants
53.1 years
STANDARD_DEVIATION 8.5 • n=107 Participants
51.8 years
STANDARD_DEVIATION 9.2 • n=206 Participants
Sex: Female, Male
Female
35 Participants
n=99 Participants
38 Participants
n=107 Participants
73 Participants
n=206 Participants
Sex: Female, Male
Male
20 Participants
n=99 Participants
18 Participants
n=107 Participants
38 Participants
n=206 Participants

PRIMARY outcome

Timeframe: Months 1-24

A unique hypertensive period served as the unit of analysis. A hypertensive period started on the first day during the study when a patient's BP was elevated. It ended on the first subsequent day when it was \<140/90 mm Hg or on the last day BP was recorded during the study. Duration of the hypertensive period (days) was the outcome measure. BP measurements obtained in the course of routine care were used to ascertain study outcomes, whether obtained by the PCP or at other clinic visits. These measurements were obtained from structured data (ie, BP recordings in the electronic medical record) and natural language processing of provider notes as previously described. If several measurements were recorded on the same day, the lowest mean arterial BP was used.

Outcome measures

Outcome measures
Measure
SE Game Cohort
n=55 Participants
SE game clinicians were e-mailed one question every 3 days. Adaptive game mechanics re-sent questions in 12 or 24 days if answered incorrectly or correctly, respectively. Clinicians retired questions by answering each correctly twice consecutively. Posting of relative performance among peers fostered competition.
Control Cohort
n=56 Participants
Control clinicians received identical educational content in an online posting with email reminders.
Cross-cohort Comparison of the Average Time Needed to Normalize Patients' Blood Pressure
137 days
Interval 0.0 to 365.0
145 days
Interval 0.0 to 365.0

SECONDARY outcome

Timeframe: Months 1-12

Population: PI and project staff no longer have access to the raw data and are no longer able to generate any more data analyses.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Months 1-12

Population: PI and project staff no longer have access to the raw data and are no longer able to generate any more data analyses.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Months 13-24

Population: PI and project staff no longer have access to the raw data and are no longer able to generate any more data analyses.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Months 13-24

Population: PI and project staff no longer have access to the raw data and are no longer able to generate any more data analyses.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Months 1-24

Population: PI and project staff no longer have access to the raw data and are no longer able to generate any more data analyses.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Months 1-24

Population: PI and project staff no longer have access to the raw data and are no longer able to generate any more data analyses.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Months 1-24

Population: PI and project staff no longer have access to the raw data and are no longer able to generate any more data analyses.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Months 1-24

Population: PI and project staff no longer have access to the raw data and are no longer able to generate any more data analyses.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Month 1

Population: PI and project staff no longer have access to the raw data and are no longer able to generate any more data analyses.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Months 1-12

Population: PI and project staff no longer have access to the raw data and are no longer able to generate any more data analyses.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Months 1-12

Population: PI and project staff no longer have access to the raw data and are no longer able to generate any more data analyses.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Months 1-12

Population: PI and project staff no longer have access to the raw data and are no longer able to generate any more data analyses.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Months 1-12

Population: PI and project staff no longer have access to the raw data and are no longer able to generate any more data analyses.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Months 1-12

Population: PI and project staff no longer have access to the raw data and are no longer able to generate any more data analyses.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Months 1-12

Population: PI and project staff no longer have access to the raw data and are no longer able to generate any more data analyses.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Months 1-12

Population: PI and project staff no longer have access to the raw data and are no longer able to generate any more data analyses.

Outcome measures

Outcome data not reported

Adverse Events

Arm 1

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Arm 2

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. B. Price Kerfoot

Veterans Affairs Boston Healthcare System

Phone: 7742869230

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place